Camilla Duborn

Camilla Duborn is an accomplished executive with extensive experience in the life sciences sector. Currently serving as CEO of Nordic BioSite since April 2022, Duborn previously held multiple senior roles at Svar Life Science AB, including Chief Commercial Officer and Senior Director positions in Global Sales & Marketing and Sales for EMEA & APAC from April 2018 to April 2022. Prior experience includes working as an Account Manager at AbD Serotec, a Bio-Rad Company from November 2014 to April 2018, and in Business Development & Marketing at Thermo Fisher Scientific from August 2011 to November 2014. Duborn's career began at Phadia AB, where various roles were held from 2003 to August 2011. Academically, Duborn holds a Magisterexamen in Molecular Biology from Uppsala University and an Executive MBA from Chefakademin.